Report #2894306

Received Apr 27, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	—

Symptoms (1)

Abdominal distension

Symptom narrative

significant swelling at injection site at 3 hours; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site swelling in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 30 hrs after receiving Shingles vaccine, the patient experienced injection site swelling (Verbatim: significant swelling at injection site at 3 hours). The outcome of the injection site swelling was not reported. It was unknown if the reporter considered the injection site swelling to be related to Shingles vaccine. It was unknown if the company considered the injection site swelling to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 08-APR-2026 The batch number was not provided, and we are unable to contact the reporter.